Cartesian Therapeutics, Inc. (RNAC)
NASDAQ·Healthcare·Biotechnology
$7.82
-3.22%
Mkt Cap $299.10M
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (5 analysts)
$20.50
Range $16.00 – $25.00
Implied Upside
+162.1%
Consensus $20.50 vs current $7.82
NASDAQ·Healthcare·Biotechnology
$7.82
-3.22%
Mkt Cap $299.10M
Buy
7
Hold
0
Sell
0
Price Target (5 analysts)
$20.50
Range $16.00 – $25.00
+162.1%
Consensus $20.50 vs current $7.82